Fifth Third Wealth Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$399K Buy
2,074
+14
+0.7% +$2.28K 0.01% 619
2026
Q2
$281K Buy
+2,060
New +$253K 0.01% 741
2026
Q1
– Sell
-1,687
Closed -$276K – 844
2025
Q4
$276K Sell
1,687
-34
-2% -$5.32K 0.01% 618
2025
Q3
$230K Buy
1,721
+6
+0.3% +$729 0.01% 678
2025
Q2
$213K Sell
1,715
-54
-3% -$6.87K 0.01% 683
2025
Q1
$225K Buy
1,769
+23
+1% +$3.54K 0.01% 625
2024
Q4
$251K Sell
1,746
-250
-13% -$35.8K 0.01% 582
2024
Q3
$297K Sell
1,996
-169
-8% -$24.2K 0.02% 474
2024
Q2
$273K Buy
+2,165
New +$339K 0.02% 446

Other funds holding RGEN

Fifth Third Wealth Advisors's RGEN Position: Q3 2026 in Review

Fifth Third Wealth Advisors increased its Repligen (RGEN) stake by 0.68% in Q3 2026, buying an estimated $2.28K and bringing the position to 2,074 shares worth $399K. The position accounts for 0.01% of the portfolio, ranked #619.

Fifth Third Wealth Advisors first reported a position in RGEN in Q2 2024 and has held it in 9 quarters since. 85 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Fifth Third Wealth Advisors held 2,074 shares of Repligen worth $399K as of Q3 2026.
  • Fifth Third Wealth Advisors bought 14 Repligen shares in Q3 2026, an estimated $2.28K.
  • Repligen made up 0.01% of Fifth Third Wealth Advisors's portfolio in Q3 2026, its #619 holding.
  • Fifth Third Wealth Advisors first reported a position in Repligen in Q2 2024 and has held it in 9 quarters since.
  • 85 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Fifth Third Wealth Advisors's 13F filing for Q3 2026, filed 22 Oct 2026.